Brokerages forecast that Dextera Surgical Inc. (NASDAQ:DXTR) will report ($0.06) earnings per share (EPS) for the current quarter, Zacks Investment Research reports. Two analysts have issued estimates for Dextera Surgical’s earnings. The lowest EPS estimate is ($0.07) and the highest is ($0.05). Dextera Surgical reported earnings of ($0.44) per share during the same quarter last year, which would suggest a positive year over year growth rate of 86.4%. The firm is expected to issue its next quarterly earnings report on Monday, November 6th.

According to Zacks, analysts expect that Dextera Surgical will report full-year earnings of ($0.24) per share for the current financial year, with EPS estimates ranging from ($0.27) to ($0.20). For the next fiscal year, analysts anticipate that the company will post earnings of ($0.19) per share. Zacks’ EPS averages are an average based on a survey of sell-side research analysts that follow Dextera Surgical.

Dextera Surgical (NASDAQ:DXTR) last released its quarterly earnings data on Tuesday, August 8th. The medical instruments supplier reported ($0.40) earnings per share for the quarter, missing the Thomson Reuters’ consensus estimate of ($0.11) by $0.29. The company had revenue of $1.05 million during the quarter, compared to the consensus estimate of $1.03 million.

A number of research analysts recently commented on the company. Zacks Investment Research cut Dextera Surgical from a “hold” rating to a “sell” rating in a research note on Tuesday, May 9th. Wedbush reduced their target price on Dextera Surgical from $3.50 to $0.70 and set an “outperform” rating on the stock in a research note on Wednesday, July 12th. Finally, Ladenburg Thalmann Financial Services assumed coverage on Dextera Surgical in a research note on Wednesday. They issued a “buy” rating and a $0.80 target price on the stock.

Dextera Surgical (NASDAQ DXTR) traded up 12.00% during midday trading on Wednesday, hitting $0.28. The company had a trading volume of 3,750,727 shares. The firm’s market capitalization is $2.50 million. The firm’s 50 day moving average is $0.27 and its 200-day moving average is $0.68. Dextera Surgical has a 52 week low of $0.17 and a 52 week high of $2.44.

ILLEGAL ACTIVITY NOTICE: This news story was originally published by American Banking News and is the property of of American Banking News. If you are reading this news story on another site, it was illegally copied and republished in violation of United States and international copyright legislation. The correct version of this news story can be viewed at

An institutional investor recently raised its position in Dextera Surgical stock. Virtu KCG Holdings LLC increased its position in shares of Dextera Surgical Inc. (NASDAQ:DXTR) by 1,380.6% during the second quarter, according to its most recent filing with the SEC. The institutional investor owned 369,918 shares of the medical instruments supplier’s stock after buying an additional 344,933 shares during the period. Virtu KCG Holdings LLC owned 4.14% of Dextera Surgical worth $111,000 at the end of the most recent reporting period. Institutional investors and hedge funds own 7.41% of the company’s stock.

Dextera Surgical Company Profile

Dextera Surgical Inc, formerly Cardica, Inc, designs and manufactures stapling devices that enable the advancement of minimally invasive surgical procedures. The Company is engaged in commercializing and developing its MicroCutter 5/80 stapler based on its staple-on-a-strip technology for use by thoracic, pediatric, bariatric, colorectal and general surgeons.

Get a free copy of the Zacks research report on Dextera Surgical (DXTR)

For more information about research offerings from Zacks Investment Research, visit

Earnings History and Estimates for Dextera Surgical (NASDAQ:DXTR)

Receive News & Ratings for Dextera Surgical Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Dextera Surgical Inc. and related companies with's FREE daily email newsletter.